Advocates Try To Pressure NIH To Respond To Norvir Petition
Last year, several non-profit groups asked the US National Institutes of Health to grant a so-called march-in petition that would allow them to make and sell the Norvir HIV medication sold by AbbVie. Why? The drug was created with federal funds and is currently much more expensive in the US than in other countries with comparable incomes.
So far, though, the agency has not acted on the request, frustrating the advocacy groups that want to make the medicine more accessible to Americans. And so, in a bid to pressure the agency to move faster, one group conducted a survey showing most Americans are unaware their taxpayer doll...
Source: Pharmalot - September 12, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs
May 2013 Update on Medical Innovation
As the weeks go by, we try to collect stories and news coverage regarding physician-industry collaboration and the breakthroughs and successes that come from such relationships. Below is a short summary of some recent physician-industry-academic-government collaborations and the impact they have had on individual patients, the U.S. healthcare system, and beyond.
In light of the recently proposed budgets for FY 2014, numerous scientific and medical groups have urged Congress and the Obama Administration to increase funding for research. The Pharmaceutical Manufacturers and Researchers of America (PhRMA) recently note...
Source: Policy and Medicine - May 6, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
Do Alzheimer's Medications Work, Who Should Take Them?
Over the years my clients have asked me, “Should my loved one be taking any of the Alzheimer’s medications?”
By Bob DeMarco
Alzheimer's Reading Room
Over the years my answer has differed depending on how much I knew about the medications, the relative costs of the medications, and how much research has been done on the effectiveness of the medications. Here is what I’m saying currently.
There are only 5 medicines that the FDA has approved for treatment of Alzheimer’s disease.
None of the medications cure the disease. None of the medications stop the disease process from continuing on long term,...
Source: Alzheimer's Reading Room, The - April 15, 2013 Category: Dementia Authors: Bob DeMarco Source Type: blogs
